Cannabis Pharmacology Beyond THC and CBD: How Terpenes and Lesser-Known Compounds Contribute to the Plant's Effects
A comprehensive pharmacology review finds that cannabis's therapeutic potential extends far beyond THC and CBD, with terpenes, flavonoids, and other plant compounds contributing meaningful pharmacological activity and synergistic interactions.
Quick Facts
What This Study Found
This major review, authored by leading cannabis researchers, argued that the pharmacology of cannabis cannot be reduced to THC and CBD alone. The review covered several key areas:
Terpenoids (aromatic compounds like myrcene, limonene, pinene, linalool, and beta-caryophyllene) contribute pharmacological effects at concentrations found in cannabis, including anti-inflammatory, analgesic, anxiolytic, and anti-cancer properties. Their synergistic relationships with cannabinoids form the "entourage effect."
Lesser-known cannabinoids including CBG, CBC, CBN, THCV, and CBDV each have distinct pharmacological profiles. CBD itself showed "remarkably versatile pharmacology" across pain, anxiety, psychosis, inflammation, and seizure disorders.
Other plant parts yield unique compounds: friedelin from roots, canniprene from leaves, cannabisin from seed coats, and cannflavin A from sprouts, each with independent pharmacological interest.
Key Numbers
Over 100 individual phytocannabinoids identified. Cannabis golden age of pharmacology began in the 1960s with Mechoulam's isolation of CBD and THC. Review covers terpenoids, flavonoids, and compounds from roots, leaves, seed coats, and sprouts.
How They Did This
Comprehensive narrative review covering the pharmacology of phytocannabinoids, terpenoids, flavonoids, and other cannabis-derived compounds. Authored by Ethan Russo and Jahan Marcu, prominent researchers in cannabis pharmacology.
Why This Research Matters
This review reframes cannabis from a "THC delivery system" to a complex pharmacological plant with dozens of active compounds working in concert. Understanding these interactions is essential for developing better cannabis-based medicines and for explaining why different cannabis strains or preparations produce different effects despite similar THC/CBD ratios.
The Bigger Picture
The concept of the entourage effect, where the full spectrum of cannabis compounds works together to produce effects that isolated compounds cannot replicate, has important implications for the pharmaceutical development of cannabis medicines. It raises the question of whether single-compound drugs (like pure CBD) capture the full therapeutic potential of the plant.
What This Study Doesn't Tell Us
Narrative review that synthesizes a vast literature without systematic methodology. Some of the claimed synergies are based on theoretical pharmacological reasoning rather than rigorous clinical evidence. The authors are prominent advocates for whole-plant cannabis medicine, which may influence emphasis. Many of the lesser-known compounds have limited preclinical data.
Questions This Raises
- ?Can the entourage effect be rigorously demonstrated in controlled clinical trials?
- ?Are specific terpene-cannabinoid combinations more effective for particular conditions?
- ?Will regulatory frameworks adapt to accommodate multi-compound cannabis preparations?
Trust & Context
- Key Stat:
- Over 100 phytocannabinoids plus dozens of terpenoids contribute to cannabis pharmacology
- Evidence Grade:
- Strong evidence: comprehensive review by leading researchers synthesizing decades of pharmacological research.
- Study Age:
- Published in 2017. A landmark review in cannabis pharmacology by Russo and Marcu.
- Original Title:
- Cannabis Pharmacology: The Usual Suspects and a Few Promising Leads.
- Published In:
- Advances in pharmacology (San Diego, Calif.), 80, 67-134 (2017)
- Authors:
- Russo, Ethan B(15), Marcu, Jahan
- Database ID:
- RTHC-01508
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
What is the entourage effect?
The entourage effect is the theory that the many compounds in cannabis (cannabinoids, terpenes, flavonoids) work together synergistically, producing effects that are different from and potentially greater than any single compound alone. This review provides extensive pharmacological evidence supporting this concept.
Do terpenes in cannabis actually do anything?
According to this review, yes. Terpenes like myrcene, limonene, pinene, and beta-caryophyllene have documented pharmacological activity including anti-inflammatory, pain-relieving, anti-anxiety, and anti-cancer effects. Their concentrations in cannabis, while modest, are sufficient to contribute meaningful biological activity, especially in combination with cannabinoids.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-01508APA
Russo, Ethan B; Marcu, Jahan. (2017). Cannabis Pharmacology: The Usual Suspects and a Few Promising Leads.. Advances in pharmacology (San Diego, Calif.), 80, 67-134. https://doi.org/10.1016/bs.apha.2017.03.004
MLA
Russo, Ethan B, et al. "Cannabis Pharmacology: The Usual Suspects and a Few Promising Leads.." Advances in pharmacology (San Diego, 2017. https://doi.org/10.1016/bs.apha.2017.03.004
RethinkTHC
RethinkTHC Research Database. "Cannabis Pharmacology: The Usual Suspects and a Few Promisin..." RTHC-01508. Retrieved from https://rethinkthc.com/research/russo-2017-cannabis-pharmacology-the-usual
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.